Clinical • Trial completion • Trial completion date • Trial primary completion date • CAR T-Cell Therapy
|
EGFR (Epidermal growth factor receptor) • MGMT (6-O-methylguanine-DNA methyltransferase) • TERT (Telomerase Reverse Transcriptase)
|
EGFR amplification • MGMT promoter methylation • TERT mutation • EGFRvIII expression • TERT promoter mutation
|
Keytruda (pembrolizumab) • LXF821